Galileo Biotech Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Galileo Biotech General Information
Description
Developer of biopharmaceutical technology that develops new treatments for unmet medical needs, particularly cancer, by harnessing and leveraging the power of the immune system. The company provides technology like therapeutic monoclonal antibodies and antibody-drug conjugates, offering solutions for patients suffering from diseases for which there are currently no satisfactory treatments.
Contact Information
Website
www.galileobio.com(Operating Subsidiary)
Corporate Office
- Rio de Janeiro, Rio De Janeiro
- Brazil
Corporate Office
- Rio de Janeiro, Rio De Janeiro
- Brazil
Galileo Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Galileo Biotech FAQs
-
When was Galileo Biotech founded?
Galileo Biotech was founded in 2015.
-
Where is Galileo Biotech headquartered?
Galileo Biotech is headquartered in Rio de Janeiro, Brazil.
-
What industry is Galileo Biotech in?
Galileo Biotech’s primary industry is Biotechnology.
-
Is Galileo Biotech a private or public company?
Galileo Biotech is a Private company.
-
What is Galileo Biotech’s current revenue?
The current revenue for Galileo Biotech is .
-
When was Galileo Biotech acquired?
Galileo Biotech was acquired on 23-Aug-2023.
-
Who acquired Galileo Biotech?
Galileo Biotech was acquired by Antharis Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process